<sup>18</sup>F-FDG and <sup>18</sup>F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K/Akt/mTOR Therapies-Reference-Cited by-同舟云学术

¹⁸F-FDG and ¹⁸F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K/Akt/mTOR Therapies

Published:2023-02-01 Issue:1 Volume:38 Page:51-61
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Dockx Yanina¹^ORCID,Vangestel Christel¹²,De Bruycker Sven¹³^ORCID,Van den Wyngaert Tim¹²,Huizing Manon⁴,Staelens Steven¹,Stroobants Sigrid¹²

Affiliation:

1. Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium.

2. Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.

3. Department of Science and Technology, AP University of Applied Sciences and Arts Antwerp, Antwerp, Belgium.

4. Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2022.0061

Reference34 articles.

1. Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer

2. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

3. Trastuzumab: triumphs and tribulations

4. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

5. Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer;International Journal of Molecular Sciences;2023-04-12